Curaleaf Holdings (CURLF) Shares Outstanding (Diluted Average) (2020 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Shares Outstanding (Diluted Average) of $762.1 million in Q4 2025, up 2.87% quarter-over-quarter from $740.8 million in Q4 2024, and up 2.87% on a YoY basis from $740.8 million in Q4 2024.
Curaleaf Holdings (CURLF) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends
Curaleaf Holdings' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $762.1 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Diluted Average) rose 2.87% year-over-year to $762.1 million; the TTM figure through Dec 2025 stood at $762.1 million (up 2.87% YoY), while the FY2025 annual figure was $762.1 million, up 2.87% from the prior year.
- Shares Outstanding (Diluted Average) was $762.1 million for Q4 2025 at Curaleaf Holdings, up from $740.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $762.1 million in Q4 2025 to a low of $724.1 million in Q4 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $742.3 million across 3 years, with a median of $740.8 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) climbed 2.31% in 2024, then rose 2.87% in 2025.
- A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $724.1 million in 2023, then increased by 2.31% to $740.8 million in 2024, then gained by 2.87% to $762.1 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $762.1 million (Q4 2025), $740.8 million (Q4 2024), and $724.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 762.09 Mn |
| Dec 31, 2024 | 740.83 Mn |
| Dec 31, 2023 | 724.12 Mn |
| Dec 31, 2020 | 557.19 Mn |